Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19329328rdf:typepubmed:Citationlld:pubmed
pubmed-article:19329328lifeskim:mentionsumls-concept:C0054943lld:lifeskim
pubmed-article:19329328lifeskim:mentionsumls-concept:C1441547lld:lifeskim
pubmed-article:19329328lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:19329328lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:19329328lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:19329328pubmed:issue8lld:pubmed
pubmed-article:19329328pubmed:dateCreated2009-4-13lld:pubmed
pubmed-article:19329328pubmed:abstractTextOverexpression of zinc-dependent metalloproteinase, aminopeptidase N (APN/CD13), is considered to be involved in the process of tumor invasion and metastasis. Herein we describe the synthesis and in vitro enzymatic inhibition assay of antineoplaston AS2-5 scaffold peptidomimetic compounds. The results demonstrated that most of these L-iso-glutamine derivatives displayed selective inhibitory activity against APN as compared with MMP-2, with IC(50) values in the micromole range. The structure-activity relationships were also briefly discussed.lld:pubmed
pubmed-article:19329328pubmed:languageenglld:pubmed
pubmed-article:19329328pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19329328pubmed:citationSubsetIMlld:pubmed
pubmed-article:19329328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19329328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19329328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19329328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19329328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19329328pubmed:statusMEDLINElld:pubmed
pubmed-article:19329328pubmed:monthAprlld:pubmed
pubmed-article:19329328pubmed:issn1464-3391lld:pubmed
pubmed-article:19329328pubmed:authorpubmed-author:HubertJ PJPJrlld:pubmed
pubmed-article:19329328pubmed:authorpubmed-author:LiXunXlld:pubmed
pubmed-article:19329328pubmed:authorpubmed-author:XuWenfangWlld:pubmed
pubmed-article:19329328pubmed:authorpubmed-author:LiYonggangYlld:pubmed
pubmed-article:19329328pubmed:authorpubmed-author:FanRuifangRlld:pubmed
pubmed-article:19329328pubmed:authorpubmed-author:WangJunliJlld:pubmed
pubmed-article:19329328pubmed:authorpubmed-author:WuJifengJlld:pubmed
pubmed-article:19329328pubmed:authorpubmed-author:LiJinpeiJlld:pubmed
pubmed-article:19329328pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19329328pubmed:day15lld:pubmed
pubmed-article:19329328pubmed:volume17lld:pubmed
pubmed-article:19329328pubmed:ownerNLMlld:pubmed
pubmed-article:19329328pubmed:authorsCompleteYlld:pubmed
pubmed-article:19329328pubmed:pagination3053-60lld:pubmed
pubmed-article:19329328pubmed:meshHeadingpubmed-meshheading:19329328...lld:pubmed
pubmed-article:19329328pubmed:meshHeadingpubmed-meshheading:19329328...lld:pubmed
pubmed-article:19329328pubmed:meshHeadingpubmed-meshheading:19329328...lld:pubmed
pubmed-article:19329328pubmed:meshHeadingpubmed-meshheading:19329328...lld:pubmed
pubmed-article:19329328pubmed:meshHeadingpubmed-meshheading:19329328...lld:pubmed
pubmed-article:19329328pubmed:meshHeadingpubmed-meshheading:19329328...lld:pubmed
pubmed-article:19329328pubmed:meshHeadingpubmed-meshheading:19329328...lld:pubmed
pubmed-article:19329328pubmed:meshHeadingpubmed-meshheading:19329328...lld:pubmed
pubmed-article:19329328pubmed:meshHeadingpubmed-meshheading:19329328...lld:pubmed
pubmed-article:19329328pubmed:year2009lld:pubmed
pubmed-article:19329328pubmed:articleTitleNovel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).lld:pubmed
pubmed-article:19329328pubmed:affiliationSchool of Pharmaceutical Sciences, Shandong University, No. 44 WenhuaXi Road, Ji'nan, 250012, Shandong Province, PR China.lld:pubmed
pubmed-article:19329328pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:19329328lld:chembl